Xingfang Su

516 total citations
11 papers, 421 citations indexed

About

Xingfang Su is a scholar working on Molecular Biology, Biomaterials and Organic Chemistry. According to data from OpenAlex, Xingfang Su has authored 11 papers receiving a total of 421 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Biomaterials and 2 papers in Organic Chemistry. Recurrent topics in Xingfang Su's work include RNA Interference and Gene Delivery (5 papers), Nanoparticle-Based Drug Delivery (3 papers) and Advancements in Transdermal Drug Delivery (2 papers). Xingfang Su is often cited by papers focused on RNA Interference and Gene Delivery (5 papers), Nanoparticle-Based Drug Delivery (3 papers) and Advancements in Transdermal Drug Delivery (2 papers). Xingfang Su collaborates with scholars based in United States, China and Singapore. Xingfang Su's co-authors include Darrell J. Irvine, Daniel G. Kavanagh, Paula T. Hammond, Byeong‐Su Kim, Nicole Yang, K. Dane Wittrup, Madhavan Nallani, Lucia Mori, Xinlu Cheng and David Erhardt and has published in prestigious journals such as Advanced Materials, ACS Nano and Biomacromolecules.

In The Last Decade

Xingfang Su

11 papers receiving 417 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xingfang Su United States 6 255 98 86 79 68 11 421
Wade Wang United States 10 306 1.2× 106 1.1× 92 1.1× 108 1.4× 38 0.6× 13 544
Maria Pelliccia Italy 12 307 1.2× 132 1.3× 61 0.7× 113 1.4× 28 0.4× 13 549
Jasmine Edelstein United States 6 186 0.7× 151 1.5× 50 0.6× 97 1.2× 35 0.5× 8 470
Marie‐Luce De Temmerman Belgium 8 234 0.9× 129 1.3× 199 2.3× 128 1.6× 88 1.3× 8 528
Elizabeth J. Curvino United States 7 227 0.9× 94 1.0× 123 1.4× 83 1.1× 21 0.3× 9 413
Christine C. Conwell United States 12 608 2.4× 175 1.8× 63 0.7× 141 1.8× 45 0.7× 15 898
Ken‐ichiro Hiwatari Japan 15 304 1.2× 171 1.7× 70 0.8× 88 1.1× 56 0.8× 30 608
Fiona MacLaughlin United States 6 513 2.0× 127 1.3× 82 1.0× 61 0.8× 39 0.6× 7 697
Sarah L. Goh United States 8 267 1.0× 101 1.0× 104 1.2× 84 1.1× 29 0.4× 11 469
Kimberly L. Douglas Canada 5 343 1.3× 168 1.7× 36 0.4× 74 0.9× 48 0.7× 5 570

Countries citing papers authored by Xingfang Su

Since Specialization
Citations

This map shows the geographic impact of Xingfang Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingfang Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingfang Su more than expected).

Fields of papers citing papers by Xingfang Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xingfang Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingfang Su. The network helps show where Xingfang Su may publish in the future.

Co-authorship network of co-authors of Xingfang Su

This figure shows the co-authorship network connecting the top 25 collaborators of Xingfang Su. A scholar is included among the top collaborators of Xingfang Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xingfang Su. Xingfang Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Li, Junjie, Xiujie Zhang, Yi Hu, et al.. (2015). [Analysis on willingness to pay for HIV antibody saliva rapid test and related factors].. PubMed. 36(2). 132–5. 2 indexed citations
2.
Su, Xingfang, et al.. (2013). Hybrid polymersomes: facile manipulation of vesicular surfaces for enhancing cellular interaction. Journal of Materials Chemistry B. 1(42). 5751–5751. 11 indexed citations
3.
Su, Xingfang, Nicole Yang, K. Dane Wittrup, & Darrell J. Irvine. (2013). Synergistic Antitumor Activity from Two-Stage Delivery of Targeted Toxins and Endosome-Disrupting Nanoparticles. Biomacromolecules. 14(4). 1093–1102. 1 indexed citations
4.
Su, Xingfang, Nicole Yang, K. Dane Wittrup, & Darrell J. Irvine. (2013). Synergistic Antitumor Activity from Two-Stage Deliveryof Targeted Toxins and Endosome-Disrupting Nanoparticles. Europe PMC (PubMed Central). 18 indexed citations
5.
Su, Xingfang, et al.. (2011). In vitro and in vivo mRNA delivery using lipid-enveloped pHresponsive polymer nanoparticles. DSpace@MIT (Massachusetts Institute of Technology). 7 indexed citations
6.
Su, Xingfang, et al.. (2011). In Vitro and in Vivo mRNA Delivery Using Lipid-Enveloped pH-Responsive Polymer Nanoparticles. Molecular Pharmaceutics. 8(3). 774–787. 236 indexed citations
7.
DeMuth, Peter C., Xingfang Su, Raymond E. Samuel, Paula T. Hammond, & Darrell J. Irvine. (2010). Nano‐Layered Microneedles for Transcutaneous Delivery of Polymer Nanoparticles and Plasmid DNA. Advanced Materials. 22(43). 4851–4856. 3 indexed citations
8.
DeMuth, Peter C., Xingfang Su, Raymond E. Samuel, Paula T. Hammond, & Darrell J. Irvine. (2010). Drug Delivery: Nano‐Layered Microneedles for Transcutaneous Delivery of Polymer Nanoparticles and Plasmid DNA (Adv. Mater. 43/2010). Advanced Materials. 22(43). 4783–4783. 1 indexed citations
9.
Su, Xingfang, et al.. (2009). Layer-by-Layer-Assembled Multilayer Films for Transcutaneous Drug and Vaccine Delivery. ACS Nano. 3(11). 3719–3729. 131 indexed citations
10.
Cheng, Xinlu, et al.. (2006). Theoretical studies of C–NO2 bond dissociation energies for chain nitro compounds. Journal of Molecular Structure THEOCHEM. 807(1-3). 43–47. 6 indexed citations
11.
Tumosa, Charles S., David Erhardt, Marion F. Mecklenburg, & Xingfang Su. (2004). Linseed Oil Paint as Ionomer: Synthesis and Characterization. MRS Proceedings. 852. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026